|
PXL/HO/Cir-021/2025-26 Date: 28.05.2025
Hyderabad
Subject:MoU between Indian Pharmacopoeia Commission (IPC) and Ministry of Health & Medical Services (MoHMS), Republic of Fiji – Webinar on Opportunities in the Fijian Market on 3rd June 2025
Dear Members,
We are pleased to inform you that the Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Ministry of Health & Medical Services (MoHMS), Republic of Fiji. This landmark agreement establishes a framework for the recognition of the Indian Pharmacopoeia (IP) as a pharmacopoeial standard for evaluating Market Authorization applications for medicinal products manufactured in India.
This development is expected to significantly ease regulatory procedures and facilitate greater market access for Indian pharmaceutical products in Fiji.
In this context, Pharmexcil, in collaboration with the High Commission of India to Fiji, is organizing a webinar on 3rd June 2025 at 10:00 AM – 12:00 PM IST. The objective of the session is to create awareness among Indian pharmaceutical exporters and manufacturers regarding:
-
Emerging trade opportunities in the Fijian pharmaceutical market
-
Key regulatory changes following the MoU
-
Strategic guidance for navigating the market authorization process in Fiji
The tentative agenda of the webinar is also attached for your kind reference.
Meeting Details: Emerging Opportunities for Indian Pharma in the Fijian Market
Date: 3rd June 2025 (Tuesday)
Time: 10:00 AM – 12:00 PM IST
Click here to register
We strongly encourage all our members to participate in this important webinar and explore the promising opportunities in Fiji's growing healthcare sector.
With best regards,
Raja Bhanu K
Director General
Encl:
|
